Inventor

GOSSEL MATTHIAS

DE46 patents

⚠️ This page may combine multiple inventors who share the name “GOSSEL MATTHIAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GOSSEL MATTHIAS

AVENTIS PHARMA GMBH

Derivatives of C2-substituted indan-1-ol compounds, methods for their preparation and use

Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity

C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals

Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity

C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals

Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity

Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity

Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity

Polysubstituted indan-1-ol compounds, and methods for their preparation and use

C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals

8,8a-dihydroindeno[1,2-d]thiazole derivatives which carry in the 2-position a substituent having a sulfonamide structure or sulfone structure; processes for their preparation and their use as medicaments

8,8a-dihydroindeno[1,2-d]thiazole derivatives which carry in the 2-position a substituent having a sulfonamide structure or sulfone structure; processes for their preparation and their use as medicaments

Substituted N-aryl heterocycles, process for their preparation and their use as medicaments

Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity

C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals

Substituted 8,8a-dihydro-3ah-indeno[1,2-d]thiazoles, processes for their preparation and their use as medicaments

8,8A-dihydroindeno[1,2-D] thiazole derivatives which are substituted in the 8A-position; processes for their preparation and their use as medicaments

Polycyclic dihydrothiazoles having substituted alkyl radicals in the two-position, process for their preparation, and their use as pharmaceuticals

SANOFI AVENTIS DEUTSCHLAND

Aryl-substituted heterocycles, process for their preparation and their use as medicaments

Substituted N-aryl heterocycles, process for their preparation and their use as medicaments

Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament

Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids

Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament

Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament

Substituted diaryl heterocycles, process for their preparation and their use as medicaments

Use of C2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity

Substituted hexahydropyrazino [1,2-A] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments

Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments

Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments

C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals

Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments

SCHWINK LOTHAR

Use of aryl-substituted polycyclic amines as medicaments

Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs

Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Aryl-substituted heterocycles, process for their preparation and their use as medicaments

Substituted indanes, method for the production thereof, and use thereof as drugs

Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament

Amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments

Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments

Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments

Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments

Aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments

SANOFI SA

Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

SANOFI AVENTIS

Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use